Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:approvedBy |
gptkb:FDA
1970 |
| gptkbp:ATCCode |
J07AX01
|
| gptkbp:boosterRecommended |
yes
|
| gptkbp:brand |
gptkb:BioThrax
|
| gptkbp:broadcastOn |
series of 5 doses
|
| gptkbp:contains |
anthrax protective antigen
|
| gptkbp:contraindication |
severe allergic reaction to previous dose
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:form |
suspension for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
anthrax vaccine adsorbed
|
| gptkbp:indication |
adults at high risk of anthrax exposure
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Emergent_BioSolutions
|
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:sideEffect |
fatigue
injection site reaction muscle aches |
| gptkbp:storage |
2-8°C
|
| gptkbp:usedBy |
gptkb:military
certain animal handlers laboratory workers |
| gptkbp:usedFor |
prevention of anthrax
|
| gptkbp:WHOStatus |
not on WHO essential medicines list
|
| gptkbp:bfsParent |
gptkb:BioThrax
|
| gptkbp:bfsLayer |
5
|